Background
Myocardial infarction (MI) is the leading cause of morbidity, mortality, and disability in the worldwide and remains one of the greatest challenges in biomedical research [
1]. Current treatments including primary percutaneous coronary intervention, coronary artery bypass graft, or thrombolysis have significantly improved outcomes but do not restore myocardial damage after MI [
2]. Consequently, new strategies such as cardiac cell therapy, tissue engineering, and gene therapy are being evaluated in pre-clinical models of disease [
3]. Thus, for clinical translation, it is necessary to identify the best experimental model that mimics human MI conditions.
Numerous animal models evaluate the pathophysiological mechanisms of ventricular remodeling and MI development and progression [
4,
5]. Briefly, swine are mostly used because of their high similarity to humans, as they share minimal pre-existing coronary collaterals and have a similar coronary physiology and anatomy [
6]. Despite acceleration of early myocardial healing process in swine compared to humans [
7], histopathologic changes after MI are common with an earliest myocardial necrosis followed by infiltration of myofibroblast and inflammatory cells (i.e. neutrophils, macrophages, lymphocytes and plasma cells), and necrotic tissue replacement by collagen I and III [
8]. MI pig model by permanent arterial occlusion can be induced following intracoronary ethanol administration [
9], cryo-injury, cauterization [
6], surgical ligation [
10], and coil embolization [
11]. Although ethanol, cryo-injury and cauterization are feasible and easily reproducible, these techniques promote pathophysiological changes different than those observed in humans [
6]. Surgical coronary ligation causes irreversible damage to the myocardium and has been used extensively to assess cardiac regeneration following cell-based therapy and tissue engineering approaches. However, in contrast to human MI, the downside of this model involves an open-chest surgery. Alternatively, closed-chest options based on permanent coronary occlusion by coil deployment avoid the hassles of surgery, adjacent scarring, and post-operative inflammation.
The presented work aims to compare infarct size, histological traits and cardiac functional changes following surgical ligation or coil deployment. All interventions were performed in the first marginal branch of the circumflex coronary artery in swine and the follow-up period was 35 days.
Discussion
The results of this study confirm that MI, either by surgical occlusion or coil deployment, is similar in terms of infarct size, cardiac function impairment, and myocardial fibrosis, but presents significant differences in myocardial vascularization and inflammation properties when the two techniques are compared.
Currently, MI experimental studies are crucial for testing efficiency of cardiac cell therapy and tissue engineering and ultimately for translational medicine. In this field of research, swine are extremely well suited animals. Several MI models have been suggested for surgical approaches and percutaneous techniques. Although surgical models allow direct visual MI assessment, are feasible, and presume to be easily reproducible, they have an undesired mortality rate (10-50%) and involve open-chest surgery [
12]. Moreover, an open-chest approach increases the risk of infections [
13] and comprises postoperative reactive inflammation as well as the establishment of new epicardial collateral vessels [
14]. Collectively, these represent substantial differences in comparison with human MI. In the present work a coronary occlusion on the marginal branch of the left circumflex artery was performed to reduce mortality caused by MI induction and evolution. Indeed, in our hands, there was no evidence of arrhythmias or lethal events recorded in these animal series.
Cardiac MRI has become the gold-standard for assessing ventricular function due to its high reproducibility; in addition, this procedure requires fewer animals to evaluate a hypothesis regarding adverse remodeling data [
15]. In the present study, MRI analysis demonstrated that global cardiac functional parameters such as LVEF, LVESV, LVEDV and CO did not differ between the two groups 35 days after MI induction. However, LVEF and cardiac output have appeared higher after the MI than at baseline. This result may be partly explained by the juvenile swine model which is still growing with immature cardiac function; by the limited infarct size caused by occluding the first marginal branch of the circumflex coronary artery; and also eventually by cardiac remodelling and neurohormonal activation driven by the cardiac injury. Although there was no LVEF impairment, all animals suffered an adverse remodeling process after MI induction where ventricular volumes significantly increased at sacrifice. It is well known that LVESV is an important parameter to evaluate heart failure progression after MI and, consequently, is directly responsible for the remodeling phenomena [
16,
17]. Moreover, myocardial remodeling also includes cell apoptosis, necrosis, and alteration of the balance between myocardial extracellular matrix and collagen fiber synthesis and degradation [
18]. In this study, myocardial fibrosis was present after MI and was similar in all animals with comparable CVF values and collagen I/III ratios in the infarcted zone.
On the other hand, the inflammatory response after MI is crucial for myocardial healing and repair, diminishing tissue injury and regulating scar formation [
19]. The inflammatory process is characterized by an early macrophage and neutrophil infiltration, specific complement activation, secretion of cytokines and, lastly, increasing levels of T and B cells [
20]. Notably, Varda-Bloom
et al. also described a slight mononuclear inflammation in the remote areas of infarcted hearts, finding lymphocytes between healthy muscle fibers. Our findings confirm this presence both in coronary surgical ligation and coil embolization models. In particular, the level of CD3+ cells in the remote myocardium was notably increased after open-chest model although not so activated as in coil embolization model. In addition, lymphocyte activation (normalized to the total number of CD3
+ cells) was also increased in the infarcted area of coil animals. Thus, lymphocyte infiltration in the whole heart after MI is more evident after coronary surgical ligation, probably due to the open-chest approach, as Li
et al. suggested [
13]. However, further long-term studies are needed to evaluate whether lymphocyte activation remains preserved over time leading to deleterious consequences. Furthermore, the higher lymphocyte activation after coil embolization could be explained by the chronic inflammation reaction at the interface between coil and tissue [
21]. Hence, the findings presented here support to a better understanding of myocardial inflammation and remodeling processes after MI and also provide new key information to determine the correct MI model.
Interestingly, the growth of subendocardial collateral vessels after acute coronary occlusion has been described both in pigs [
22] and humans [
23], and was reported as a critical mechanism in the cardiac tissue salvage after injury. As mentioned above, the newly formed neo-vessels after the open-chest approach [
11] could also improve myocardial healing, differing from what occurs in the natural human MI process, Although Isolectin B4 staining does not distinguish newly formed vessels, this assumption is suggested from our results due the vascular similarities found between the infarct and border zones with remote healthy myocardium after surgical coronary ligation. On the contrary, myocardial vascularization after MI was significantly diminished in infarcted and border zones in animals operated on the closed-chest approach, as in humans. Although these differences do not alter the infarct size or ventricular function, they should be considered when conducting studies of vascularization after MI. Consequently, coronary surgical occlusion may not be the most representative of clinical coronary ischemic events and alternatives closely resembling pathophysiological traits in humans should be used. Closed-chest percutaneous techniques, which avoid the new collateral development that occurs with open-chest procedures, appear to be a good option, including permanent balloon occlusion and embolization coils [
24]. Balloon coronary angioplasty triggers frequent ventricular fibrillation with high mortality rates and its use is better suited in ischemia/reperfusion rather than permanent occlusion studies [
12]. In contrast, coil embolization can be applied at any point of the coronary tree to model acute and chronic MI, or chronic congestive heart failure [
18]. This alternative appears to be an excellent choice for cell-based therapy, cardiac tissue engineering, gene therapy, and pharmacologic studies in MI in comparison to open-chest coronary occlusion that could interfere with results and may hamper translation to humans.
Conclusion
In summary, our results support that surgical occlusion and coil embolization MI models generate similar infarct size, cardiac function impairment, and myocardial fibrosis in swine. However, both inflammation and myocardial vascularization levels were closer to those found in humans when coil embolization was performed. Therefore we suggest the use of coil embolization in pre-clinical MI research, being a better MI model than surgical coronary ligation, to obtain reliable results and leading to prompt clinical applications.
Limitations of the study
Landrace × Large White prepuberal pigs were used and, thus, results may differ from an adult model. For this purpose, minipigs represent a more regular alternative although they require more complex and expensive handling. Moreover, the ischemic model used in this study produces a limited infarct size, without the induction of malignant ventricular arrhythmias and showing limited effects on ventricular function. In addition, the lack of echocardiographic monitoring prevents the evaluation of ischemic mitral valve regurgitation, frequently observed in lateral LV infarction.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CGM carried out the animal experimental set, participated in its design, performed the statistical analysis, and drafted the manuscript. CPV and IDG helped to carry out the experimental procedures. VC carried out MRI analysis. CSB, SR, ALV and IPG carried out the histological and immunohistochemical analysis and helped in acquisition data. FSM and ABG participated in its design and drafted the manuscript. All authors read and approved the final manuscript.